Korea Investment Partners backs Eloxx Pharmaceuticals' $30m Series C

Korea Investment Partners backs Eloxx Pharmaceuticals' $30m Series C

Medicine, biotechnology, DNA, genetics and healthcare. Image: Pixabay

Shiwen Yap

27 June, 2017

DSC InvestmentsEloxx PharmaceuticalsEloxx Pharmaceuticals LtdKIPKorea Investment PartnersOPKO Health Inc.PontifaxSevion Therapeutics Inc

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.